Account
Inquiry
XCE Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
As a dual agonist, XCE Tirzepatide exhibits greater affinity for GIP receptors while maintaining significant activity at GLP-1 receptors. This unique pharmacological profile results in enhanced glycemic control and metabolic effects, making it a valuable compound for scientific investigation.
The white powder formulation of XCE Tirzepatide ensures stability and ease of handling for research applications. Proper storage conditions maintain the compound's integrity for extended periods, supporting long-term study requirements.
For research use only. Not for human consumption. This product is intended solely for laboratory investigation by qualified professionals.
Kudos for the incredibly fast shipping! The package arrived securely sealed and ahead of schedule, which was a pleasant surprise. The product quality appears excellent, with proper labeling and packaging that ensures freshness. Customer service was responsive and helpful when I had a query, providing clear answers promptly. Overall, a smooth and reliable experience from start to finish. I highly recommend this supplier for their efficiency and attention to detail.
